What Is an aBLA?
abbreviated Biologics License Application
An abbreviated Biologics License Application (aBLA) contains evidence that the potential drug is biosimilar to a reference product already approved by the FDA.
An abbreviated Biologics License Application (aBLA) contains evidence that the potential drug is biosimilar to a reference product already approved by the FDA.
Copyright © 2024. Winston & Strawn LLP
AlumniCorporate Transparency Act Task ForceEqual Rights AmendmentLaw GlossaryNew Administration: The Transition Period UpdateWinston MinutePrivacy PolicyCookie PolicyNoticesSubscribeAttorney Advertising